Applied Filters:
facet applications:Vaccine manufacturing
Content Type
Applications
Vaccine manufacturing
Showing 1-1 of 1 result
BIO International
We warmly invite you to visit booth 4735 at BIO International and connect with the MilliporeSigma team.
Bioprocessing Summit
Vaccine processing evolution focuses on agile manufacturing solutions amid the COVID pandemic.
Vaccine Manufacturing
From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
Virus-Based Vaccine Manufacturing
Tailored viral vaccine manufacturing addresses virus-specific challenges through collaboration.
mRNA Vaccines and Therapeutics Manufacturing
mRNA vaccine technology offers rapid development and scalable manufacturing for disease prevention.
Plasmid DNA Vaccines Manufacturing
Learn about overcoming challenges in manufacturing pDNA vaccines, including low productivity and separation issues.
Protein Subunit Vaccine Manufacturing
This page provides an overview of protein subunit vaccines, which incorporate a recombinant protein fragment derived from the viral pathogen. It includes a description of the subunit vaccine manufacturing workflow and the products and technologies that are essential to ensure
Virus-like Particles (VLPs) Vaccine Manufacturing
VLP vaccine manufacturers must optimize upstream productivity with reliable scale-up, achieve yield and efficiency goals with robust impurity removal, maximize downstream recovery, and ensure patient safety.
Viral Vector Vaccine Mfg
A templated process produces live vector vaccines. Challenges: yield loss, filtration, aggregation, scaling. Collaboration overcomes manufacturing hurdles.
Estrategias de fabricación de vacunas y terapias de ARNm
La tecnología del ARNm ofrece versatilidad terapéutica; sus sistemas de administración inducen la producción de proteínas para diversas aplicaciones.
Page 1 of 4